Q2 2024 Holdings
Filed 2024-08-14 | 114 holdings | $3.9B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cava Group Inc(CAVA) | COM | 148929102 | $2.2B | 23,507,990 | 55.6% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $294.2M | 175,099,384 | 7.5% |
| Scholar Rock Holding Corp(SRRK) | COM | 80706P103 | $93.8M | 11,259,438 | 2.4% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $89.7M | 3,005,610 | 2.3% |
| Morphic Holding Inc | COM | 61775R105 | $86.1M | 2,525,998 | 2.2% |
| Arrowhead Pharmaceuticals Inc(ARWR) | COM | 04280A100 | $82.9M | 3,189,389 | 2.1% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $56.3M | 1,467,080 | 1.4% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $53.5M | 1,516,960 | 1.4% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $52.8M | 2,779,619 | 1.3% |
| SpringWorks Therapeutics Inc | COM | 85205L107 | $49.5M | 1,313,026 | 1.3% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $47.7M | 1,066,064 | 1.2% |
| Merus NV | COM | N5749R100 | $45.0M | 760,355 | 1.1% |
| Beigene Ltd(ONC) | SPONSORED ADR | 07725L102 | $43.3M | 303,369 | 1.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $39.4M | 1,015,776 | 1.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $37.5M | 1,819,884 | 1.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $33.1M | 915,974 | 0.8% |
| Neumora Therapeutics Inc(NMRA) | COM | 640979100 | $27.8M | 2,824,052 | 0.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $26.8M | 494,421 | 0.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $26.8M | 655,555 | 0.7% |
| Arrowhead Pharmaceuticals Inc(ARWR)Call | COM | 04280A100 | $26.0M | 1,000,000 | 0.7% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $22.9M | 3,330,422 | 0.6% |
| Wave Life Sciences Ltd(WVE) | SHS | Y95308105 | $22.8M | 4,566,251 | 0.6% |
| Erasca Inc(ERAS) | COM | 29479A108 | $22.7M | 9,630,810 | 0.6% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $21.6M | 2,519,841 | 0.6% |
| Prothena Corporation PLC(PRTA) | SHS | G72800108 | $20.7M | 1,001,360 | 0.5% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $19.1M | 2,112,500 | 0.5% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $18.5M | 1,057,949 | 0.5% |
| NewAmsterdam Pharma Company NV(NAMS) | ORDINARY SHARES | N62509109 | $15.4M | 800,000 | 0.4% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $14.9M | 381,554 | 0.4% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $14.6M | 811,718 | 0.4% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $14.2M | 2,500,000 | 0.4% |
| Korro Bio Inc(KRRO) | COM | 500946108 | $14.0M | 413,072 | 0.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $13.8M | 101,100 | 0.4% |
| Agenus Inc(AGEN) | COM NEW | 00847G804 | $13.0M | 775,000 | 0.3% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $12.9M | 2,505,013 | 0.3% |
| Gossamer Bio Inc(GOSS) | COM | 38341P102 | $12.0M | 13,308,968 | 0.3% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $11.7M | 502,899 | 0.3% |
| Ultragenyx Pharmaceutical Inc(RARE) | COM | 90400D108 | $11.3M | 275,000 | 0.3% |
| Biohaven Ltd(BHVN) | COM | G1110E107 | $10.6M | 306,703 | 0.3% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $9.8M | 4,354,214 | 0.2% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $9.7M | 603,435 | 0.2% |
| Acelyrin Inc | COM | 00445A100 | $8.9M | 2,020,888 | 0.2% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $8.5M | 203,000 | 0.2% |
| Cartesian Therapeutics Inc(RNAC) | COM NEW | 816212302 | $8.2M | 304,554 | 0.2% |
| Rapport Therapeutics Inc(RAPP) | COM | 75383L102 | $8.1M | 350,000 | 0.2% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $8.1M | 1,011,500 | 0.2% |
| Generation Bio Co(GBIOGBX) | COM | 37148K100 | $8.0M | 2,830,591 | 0.2% |
| Seer Inc(SEER) | COM CL A | 81578P106 | $8.0M | 4,750,000 | 0.2% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $7.3M | 1,828,691 | 0.2% |
| Mind Medicine MindMed Inc(BRD1EUR) | COM NEW | 60255C885 | $7.3M | 1,007,875 | 0.2% |